Arrhythmogenic mitral valve prolapse and underlying cardiomyopathic substrates: a genetic case-control Study using UK Biobank and NIH all of Us
Arrhythmogenic mitral valve prolapse (aMVP) has been associated with malignant ventricular arrhythmias and sudden cardiac death(1). Whether aMVP represents a distinct genetic entity or reflects phenotypic overlap with underlying cardiomyopathic or inherited arrhythmia substrates remains unclear. To evaluat...